Improving randomized controlled trial analysis via data-adaptive borrowing
Biometrika · 16.03.2025 · 112 (2)
DOI: 10.1093/biomet/asae069 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Biometrika, online erschienen am 17.12.2024. Verfasst von Chenyin Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, North Carolina State University, 2311 Stinson Drive, Raleigh, North Carolina 27695, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, FDA HHS, Food and Drug Administration.
Abstract (Originalsprache)
In recent years, real-world external controls have grown in popularity as a tool to empower randomized placebo-controlled trials, particularly in rare diseases or cases where balanced randomization is unethical or impractical. However, as external controls are not always comparable to the trials, direct borrowing without scrutiny may heavily bias the treatment effect estimator. Our paper proposes a data-adaptive integrative framework capable of preventing unknown biases of the external controls. The adaptive nature is achieved by dynamically sorting out a comparable subset of external controls via bias penalization. Our proposed method can simultaneously achieve (a) the semiparametric efficiency bound when the external controls are comparable and (b) selective borrowing that mitigates the impact of the existence of incomparable external controls. Furthermore, we establish statistical guarantees, including consistency, asymptotic distribution and inference, providing Type-I error control and good power. Extensive simulations and two real-data applications show that the proposed method leads to improved performance over the trial-only estimator across various bias-generating scenarios.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics, North Carolina State University, 2311 Stinson Drive, Raleigh, North Carolina 27695, USA.
- Eli Lilly & Company, Lilly Corporate Center, 893 Delaware Street, Indianapolis, Indiana 46285, USA.
ORCID-Profile: Chenyin Gao, Shu Yang
Förderung
- NIA NIH HHS
- FDA HHS
- Food and Drug Administration
- U.S. Department of Health and Human Services
- National Institute on Aging
- National Institutes of Health
- FDA
- HHS
Zitieren
APA
Gao, C., Yang, S., Shan, M., Ye, W., Lipkovich, I., & Faries, D. (2025). Improving randomized controlled trial analysis via data-adaptive borrowing. Biometrika, 112(2). https://doi.org/10.1093/biomet/asae069
Vancouver
Gao C, Yang S, Shan M, Ye W, Lipkovich I, Faries D. Improving randomized controlled trial analysis via data-adaptive borrowing. Biometrika. 2025;112(2). doi:10.1093/biomet/asae069
BibTeX
@article{Gao2025,
author = {Gao, Chenyin and Yang, Shu and Shan, Mingyang and Ye, Wenyu and Lipkovich, Ilya and Faries, Douglas},
title = {Improving randomized controlled trial analysis via data-adaptive borrowing},
journal = {Biometrika},
year = {2025},
volume = {112},
number = {2},
doi = {10.1093/biomet/asae069}
}
EUVIMED